Validation of a Novel Rat-Holding Device for Studying Heat- and Mechanical-Evoked Trigeminal Nocifensive Behavioral Responses

Aims: To test the reliability and validity of a novel rat-holding device designed to be used in conjunction with the plantar test apparatus for studying nocifensive behavioral responses in an established model of temporomandibular joint (TMJ) pathology. Methods: Thirty-five young adult male Sprague-Dawley rats were used. Withdrawal latencies in response to infrared 40 heat stimulation of the submandibular region in naïve animals (n = 4) and animals injected with saline or complete Freund's adjuvant (CFA) in the TMJ (n > 9) were measured over a 2-week time period. Nocifensive responses to mechanical stimulation of the cutaneous tissue directly over the TMJ with von Frey filaments were investigated in animals injected with CFA in the TMJ (n = 6). The effect on nocifensive responses to heat and mechanical stimulation of subcutaneous administration of buprenorphine (0.05 mg/kg) into the hindquarter was assessed in CFA and cotreated animals (n = 6). Statistical analysis was performed using a nonparametric Mann-Whitney U test. Results: Under basal conditions, withdrawal latencies to heat stimulation of the orofacial region remained consistently around 15 seconds over 14 days. Unilateral CFA injection in the TMJ significantly decreased heat-withdrawal latencies on days 1, 2, 7, and 14 in the ipsilateral side (P < .05), but not contralateral side, when compared with basal values. CFA also significantly decreased the nocifensive threshold to mechanical stimulation on days 1, 2, and 7 postinjection (P < .05). CFA-mediated changes in heat withdrawal and mechanical thresholds in the orofacial region were significantly suppressed by subcutaneous administration of buprenorphine into the hindquarter (P < .05). Conclusion: Findings from this study provide evidence to validate the use of this holding device for studying nocifensive behaviors in the orofacial region of rats in response to heat or mechanical orofacial stimulation.

inflammation; plantar test; TMJ, trigeminal; von Frey

1. Hargreaves K, Dubner r, Brown f, et al. a new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988;32:77–88.

2. Bromm B, Treede rD. nerve fibre discharges, cerebral potentials, and sensations induced by cO2 laser stimulation. Hum neurobiol 1984;3:33–40.

3. Treede rD. Peripheral acute pain mechanisms. ann Med 1995;27:213–216.

4. Magerl W, ali Z, Ellrich J, et al. c- and a delta-fiber components of heat-evoked cerebral potentials in healthy human subjects. Pain 1999;82:127–137.

5. Tzabazis a, Klyukinov M, Manering n, et al. Differential activation of trigeminal c or adelta nociceptors by infrared diode laser in rats: Behavioral evidence. Brain res 2005;1037:148–156.

6. Sessle B. acute and chronic craniofacial pain: Brainstem mechanisms of nociceptive transmission and neuroplasticity and their clinical correlates. crit rev Oral Biol Med 2000;11:57–91.

7. Shankland WE ii. The trigeminal nerve. Part i: an overview. cranio 2000;18:238–248.

8. Bereiter Da, Okamoto K, Bereiter Df. Effect of persistent monoarthritis of the temporomandibular joint region on acute mustard oil-induced excitation of trigeminal subnucleus caudalis neurons in male and female rats. Pain 2005;117:58–67.

9. Shimizu K, Guo W, Wang H, et al. Differential involvement of trigeminal transition zone and laminated subnucleus caudalis in orofacial deep and cutaneous hyperalgesia: The effects of interleukin-10 and glial inhibitors. Mol Pain 2009;5:75.

10. al-Jundi Ma, John MT, Setz JM, et al. Meta-analysis of treatment need for temporomandibular disorders in adult nonpatients. J Orofac Pain 2008;22:97–107.

11. Herb K, cho S, Stiles M. Temporomandibular joint pain and dysfunctioning. curr Pain Headache rep 2006;10:408–414.

12. Dao TT, Leresche L. Gender differences in pain. J Orofac Pain 2000;14:169–184.

13. riley JL iii, Gilbert GH. Orofacial pain symptoms: an interaction between age and sex. Pain 2001;90:245–256.

14. Shinal rM, fillingim rB. Overview of orofacial pain: Epidemiology and gender differences in orofacial pain. Dent clin north am 2007;51:1–18.

15. raphael KG, Janal Mn, anathan S, et al. Temporal summation of heat pain in temporomandibular disorder patients. J Orofac Pain 2009;23:54–64.

16. fernandez-de-las-Penas c, Galan-del-rio f, Ortega-Santia- go r, et al. Bilateral thermal hyperalgesia in trigeminal and extra-trigeminal regions in patients with myofascial temporomandibular disorders. Exp Brain res 2010;202:171–179.

17. Park JW, clark GT, Kim YK, et al. analysis of thermal pain sensitivity and psychological profiles in different subgroups of TMD patients. int J Oral Maxillofac Surg 2010;39: 968–974.

18. Svensson P, cairns BE, Wang K, et al. Glutamate-evoked pain and mechanical allodynia in the human masseter muscle. Pain 2003;101:221–227.

19. Pitts WG. rodent restrainer for biomicroscopy. am J Optom Physiol Opt 1976;53:154–155.

20. Warden SJ, Bennell KL, McMeeken JM, et al. a technique for restraining rodents during hindlimb interventions. contemp Top Lab anim Sci 2000;39:24–27.

21. Sato T, Kitagawa J, ren K, et al. activation of trigeminal intranuclear pathway in rats with temporomandibular joint inflammation. J Oral Sci 2005;47:65–69.

22. Takeda M, Tanimoto T, ikeda M, et al. Temporomandibular joint inflammation potentiates the excitability of trigeminal root ganglion neurons innervating the facial skin in rats. J neurophysiol 2005;93:2723–2738.

23. neubert JK, Widmer cG, Malphurs W, et al. Use of a novel thermal operant behavioral assay for characterization of orofacial pain sensitivity. Pain 2005;116:386–395.

24. ambalavanar r, Moritani M, Moutanni a, et al. Deep tissue inflammation upregulates neuropeptides and evokes nociceptive behaviors which are modulated by a neuropeptide antagonist. Pain 2006;120:53–68.

25. Villa G, ceruti S, Zanardelli M, et al. Temporomandibular joint inflammation activates glial and immune cells in both the trigeminal ganglia and in the spinal trigeminal nucleus. Mol Pain 2010;6:89.

26. Yamazaki Y, ren K, Shimada M, et al. Modulation of paratrigeminal nociceptive neurons following temporomandibular joint inflammation in rats. Exp neurol 2008;214:209–218.

27. Zhou Q, imbe H, Dubner r, et al. Persistent fos protein expression after orofacial deep or cutaneous tissue inflammation in rats: implications for persistent orofacial pain. J comp neurol 1999;412:276–291.

28. ren K. an improved method for assessing mechanical allodynia in the rat. Physiol Behav 1999;67:711–716.

29. Green PG, alvarez P, Gear rW, et al. further validation of a model of fibromyalgia syndrome in the rat. J Pain 2011;12:811–818.

30. cho HJ, Staikopoulos V, furness JB, et al. inflammation- induced increase in hyperpolarization-activated, cyclic nucleotide-gated channel protein in trigeminal ganglion neurons and the effect of buprenorphine. neuroscience 2009;162:453–461.

31. Vadivelu n, Hines rL. Buprenorphine: a unique opioid with broad clinical applications. J Opioid Manag 2007;3:49–58.

32. Bakke M, Hu JW, Sessle BJ. Morphine application to peripheral tissues modulates nociceptive jaw reflex. neuroreport 1998;9:3315–3319.

33. fischer L, arthuri MT, Torres-chavez KE, et al. contribution of endogenous opioids to gonadal hormones-induced temporomandibular joint antinociception. Behav neurosci 2009;123:1129–1140.

34. Morgan Jr, Gebhart Gf. characterization of a model of chronic orofacial hyperalgesia in the rat: contribution of na(V) 1.8. J Pain 2008;9:522–531.

35. chicre-alcantara Tc, Torres-chavez KE, fischer L, et al. Local kappa opioid receptor activation decreases temporomandibular joint inflammation. inflammation 2012; 35:371–376.